Heartflow (HTFL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $48.29, -5.14% vs the prior close of $50.90.
- Volume 1.00M shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HTFL slides 5.1% to $48.29. Closed at $48.29, -5.14% vs the prior close of $50.90. Day range $47.97–$50.99, opened at $50.64.
HTFL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — HTFL slides 5.1% to $48.29
- Closed at $48.29, -5.14% vs the prior close of $50.90. Day range $47.97–$50.99, opened at $50.64.
- Volume was 1.00M shares, 0.5x its 50-day average of 2.05M — lighter than usual.
- Price is +3.0% vs its 50-day average ($46.86) and +46.9% vs its 200-day average ($32.86).
- 52-week range $20.13–$54.32; today's close sits at 82% of that range, 11.1% below the 52-week high.
Oct 15, 2026 — HTFL rises 2.9% to $50.90
- Closed at $50.90, +2.92% vs the prior close of $49.46. Day range $47.39–$51.84, opened at $48.37.
- Volume was 1.50M shares, 0.7x its 50-day average of 2.04M.
- Price is +9.6% vs its 50-day average ($46.44) and +55.3% vs its 200-day average ($32.77).
- 52-week range $20.13–$54.32; today's close sits at 90% of that range, 6.3% below the 52-week high.
Oct 14, 2026 — HTFL dips 1.7% to $49.46
- Closed at $49.46, -1.71% vs the prior close of $50.32. Day range $48.85–$50.87, opened at $49.46.
- Volume was 1.62M shares, 0.8x its 50-day average of 2.02M.
- Price is +7.6% vs its 50-day average ($45.97) and +51.4% vs its 200-day average ($32.67).
- 52-week range $20.13–$54.32; today's close sits at 86% of that range, 8.9% below the 52-week high.
Oct 13, 2026 — HTFL dips 0.5% to $50.32
- Closed at $50.32, -0.47% vs the prior close of $50.56. Day range $49.91–$51.57, opened at $50.84.
- Volume was 1.49M shares, 0.7x its 50-day average of 2.00M.
- Price is +10.5% vs its 50-day average ($45.52) and +54.5% vs its 200-day average ($32.57).
- 52-week range $20.13–$54.32; today's close sits at 88% of that range, 7.4% below the 52-week high.
Oct 12, 2026 — HTFL rises 1.6% to $50.56
- Closed at $50.56, +1.65% vs the prior close of $49.74. Day range $49.18–$51.69, opened at $49.75.
- Volume was 1.42M shares, 0.7x its 50-day average of 1.99M.
- Price is +12.2% vs its 50-day average ($45.05) and +55.7% vs its 200-day average ($32.47).
- 52-week range $20.13–$54.32; today's close sits at 89% of that range, 6.9% below the 52-week high.
Oct 9, 2026 — HTFL jumps 4.4% to $49.74
- Closed at $49.74, +4.43% vs the prior close of $47.63. Day range $47.26–$50.00, opened at $47.64.
- Volume was 812.80K shares, 0.4x its 50-day average of 1.99M — lighter than usual.
- Price is +11.7% vs its 50-day average ($44.54) and +53.6% vs its 200-day average ($32.37).
- 52-week range $20.13–$54.32; today's close sits at 87% of that range, 8.4% below the 52-week high.
Oct 8, 2026 — HTFL slides 3.5% to $47.63, 3 down days in a row
- Closed at $47.63, -3.50% vs the prior close of $49.36. Day range $46.50–$49.66, opened at $48.54.
- Volume was 1.99M shares, 1.0x its 50-day average of 1.97M.
- Price is +8.1% vs its 50-day average ($44.07) and +47.6% vs its 200-day average ($32.28).
- 52-week range $20.13–$54.32; today's close sits at 80% of that range, 12.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — HTFL dips 2.6% to $49.36
- Closed at $49.36, -2.62% vs the prior close of $50.69. Day range $48.44–$51.50, opened at $49.76.
- Volume was 1.44M shares, 0.7x its 50-day average of 1.97M.
- Price is +13.2% vs its 50-day average ($43.61) and +53.3% vs its 200-day average ($32.19).
- 52-week range $20.13–$54.32; today's close sits at 85% of that range, 9.1% below the 52-week high.
Oct 6, 2026 — HTFL dips 2.9% to $50.69
- Closed at $50.69, -2.91% vs the prior close of $52.21. Day range $49.51–$54.32, opened at $54.00.
- Volume was 2.91M shares, 1.5x its 50-day average of 1.95M.
- Price is +17.5% vs its 50-day average ($43.14) and +58.0% vs its 200-day average ($32.09).
- 52-week range $20.13–$54.32; today's close sits at 89% of that range, 6.7% below the 52-week high.
Oct 5, 2026 — HTFL jumps 5.9% to $52.21, a 52-week high
- Closed at $52.21, +5.86% vs the prior close of $49.32. Day range $49.29–$53.07, opened at $49.29.
- Volume was 2.45M shares, 1.3x its 50-day average of 1.92M.
- Price is +22.5% vs its 50-day average ($42.63) and +63.3% vs its 200-day average ($31.97).
- 52-week range $20.13–$53.07; today's close sits at 97% of that range, 1.6% below the 52-week high.
Oct 2, 2026 — HTFL rises 0.8% to $49.32
- Closed at $49.32, +0.84% vs the prior close of $48.91. Day range $47.33–$50.00, opened at $49.00.
- Volume was 1.64M shares, 0.9x its 50-day average of 1.90M.
- Price is +17.2% vs its 50-day average ($42.07) and +54.9% vs its 200-day average ($31.84).
- 52-week range $20.13–$52.22; today's close sits at 91% of that range, 5.6% below the 52-week high.
HTFL latest news & SEC filings
Every SEC filing by or about HTFL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Farquhar John C.M. sold 38,900 shares at $49.57 (≈$1.93M) on Oct 12, 2026; now holds 283,014
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rogers Campbell converted options/RSUs into 12,329 shares at $8.33 (≈$102.70K) on Sep 18, 2026; now holds 98,788
- Rogers Campbell converted options/RSUs into 850 shares at $2.22 (≈$1.89K) on Sep 18, 2026; now holds 99,638
- Rogers Campbell sold 19,682 shares at $50.15 (≈$987.05K) on Sep 18, 2026; now holds 79,956
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Verghese Vikram sold 7,579 shares at $50.11 (≈$379.82K) on Sep 17, 2026; now holds 171,949
- Verghese Vikram sold 16,766 shares at $50.75 (≈$850.93K) on Sep 18, 2026; now holds 155,183
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 18, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $64.08M (prior year $43.42M) (+47.6% vs Jun 30, 2025)
- Net income: -$15.74M (prior year -$9.20M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.18 (prior year -$1.46) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade HTFL
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 18, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.30% (largest 5.9%).
- Liquidity: about 1.58M shares (≈$76.11M) trade per day on average.
- 52-week position: $48.29 vs a range of $20.13–$54.32 (82% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Campbell Rogers sold 19,682 shares on Sep 18, 2026.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 13, 2026; 8-K Jun 18, 2026.
- Share count: 86.95M shares outstanding (Jul 31, 2026), +4.3% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
HTFL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 50.64 | 50.99 | 47.97 | 48.29 | 1.00M |
| Oct 15, 2026 | 48.37 | 51.84 | 47.39 | 50.90 | 1.50M |
| Oct 14, 2026 | 49.46 | 50.87 | 48.85 | 49.46 | 1.62M |
| Oct 13, 2026 | 50.84 | 51.57 | 49.91 | 50.32 | 1.49M |
| Oct 12, 2026 | 49.75 | 51.69 | 49.18 | 50.56 | 1.42M |
| Oct 9, 2026 | 47.64 | 50.00 | 47.26 | 49.74 | 812.80K |
| Oct 8, 2026 | 48.54 | 49.66 | 46.50 | 47.63 | 1.99M |
| Oct 7, 2026 | 49.76 | 51.50 | 48.44 | 49.36 | 1.44M |
| Oct 6, 2026 | 54.00 | 54.32 | 49.51 | 50.69 | 2.91M |
| Oct 5, 2026 | 49.29 | 53.07 | 49.29 | 52.21 | 2.45M |
| Oct 2, 2026 | 49.00 | 50.00 | 47.33 | 49.32 | 1.64M |
| Oct 1, 2026 | 49.81 | 51.08 | 48.84 | 48.91 | 1.28M |
| Sep 30, 2026 | 50.01 | 51.19 | 49.67 | 49.75 | 1.30M |
| Sep 29, 2026 | 50.00 | 51.00 | 48.67 | 49.83 | 2.04M |
| Sep 28, 2026 | 48.64 | 50.00 | 48.17 | 49.92 | 1.12M |
| Sep 25, 2026 | 48.93 | 49.57 | 48.10 | 49.17 | 1.16M |
| Sep 24, 2026 | 48.32 | 49.07 | 47.23 | 48.66 | 1.52M |
| Sep 23, 2026 | 49.66 | 50.70 | 46.78 | 47.39 | 2.10M |
| Sep 22, 2026 | 50.94 | 51.40 | 49.71 | 50.17 | 1.35M |
| Sep 21, 2026 | 50.62 | 51.13 | 48.51 | 50.33 | 1.38M |
About Heartflow
Heartflow (HTFL) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1464521.
HTFL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Timothy C Barabe | Director | Jul 24, 2026 |
| Julie A Cullivan | Director | Jun 18, 2026 |
| John C.M. Farquhar | Chief Executive Officer | Sep 14, 2026 |
| Partners Management Lp Healthcor | Director | Mar 26, 2026 |
| Jeffrey C Lightcap | Director | Jul 28, 2026 |
| Wayne Joseph Riley | Director | Jun 18, 2026 |
| Casey M Tansey | Director | Jun 18, 2026 |
| William C Weldon | Director | Jul 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John C.M. Farquhar | Chief Executive Officer | Sep 14, 2026 |
| Marie L. Jones | Chief Accounting Officer | Aug 10, 2026 |
| Campbell Rogers | Chief Medical Officer | Sep 21, 2026 |
| Vikram Verghese | Chief Financial Officer | Sep 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 18, 2026 | Campbell Rogers | Sale | 19,682 | $50.15 |
| Sep 18, 2026 | Campbell Rogers | Sale | 19,682 | $50.15 |
| Sep 18, 2026 | Campbell Rogers | Sale | 19,682 | $50.15 |
| Sep 18, 2026 | Campbell Rogers | Sale | 19,682 | $50.15 |
| Sep 18, 2026 | Vikram Verghese | Sale | 16,766 | $50.75 |
| Sep 18, 2026 | Vikram Verghese | Sale | 16,766 | $50.75 |
| Sep 18, 2026 | Vikram Verghese | Sale | 16,766 | $50.75 |
| Sep 18, 2026 | Vikram Verghese | Sale | 16,766 | $50.75 |
| Sep 17, 2026 | Vikram Verghese | Sale | 7,579 | $50.11 |
| Sep 17, 2026 | Vikram Verghese | Sale | 7,579 | $50.11 |
| Sep 17, 2026 | Vikram Verghese | Sale | 7,579 | $50.11 |
| Sep 17, 2026 | Vikram Verghese | Sale | 7,579 | $50.11 |
| Sep 15, 2026 | Vikram Verghese | Sale | 668 | $50.01 |
| Sep 15, 2026 | Vikram Verghese | Sale | 668 | $50.01 |
| Sep 15, 2026 | Vikram Verghese | Sale | 668 | $50.01 |
HTFL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $176.03M | $-116.79M | -3.17 | $-54.02M |
| Dec 31, 2024 | $125.81M | $-96.43M | -17.98 | $-69.00M |
| Dec 31, 2023 | $87.17M | $-95.66M | -25.32 | $-76.43M |
Latest balance sheet: total assets $344.46M, total liabilities $64.74M, cash $34.36M (as of Jun 30, 2026).
HTFL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $31.01 |
| May 14, 2026 | 8-K Item 2.02 (results) | $32.24 |
| Mar 18, 2026 | 8-K Item 2.02 (results) | $25.47 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $35.74 |
| Sep 10, 2025 | 8-K Item 2.02 (results) | $33.48 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HTFL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.